Listed
2591 INNOGEN-B
Guangzhou Innogen Pharmaceutical Group Co., Ltd.
Research, development and commercialization of innovative therapies for diabetes and other metabolic diseases
Overview
- Company
- Guangzhou Innogen Pharmaceutical Group Co., Ltd.
- Sector
- Biotechnology / Pharmaceuticals
- Market
- Main Board
- Listing date
- Aug 15, 2025
Offer Details
- Offer price
- HKD 18.68
- Board lot
- 200
- Total offer shares
- 36,556,400
- Hong Kong offer shares
- 3,655,800
- International offer shares
- 32,900,600
- Minimum application
- 200 shares
- Gross proceeds
- HKD 682,900,000
- Net proceeds
- HKD 634,700,000
Timetable
- Application deadline
- Aug 12, 2025
- Refund date
- Aug 15, 2025
- Trading start
- Aug 15, 2025
- Listing date
- Aug 15, 2025
Allocation Result
- Valid applications
- 256,072
- Subscription multiple
- 5,341.66x
- One-lot success rate
- 0.5%
- Successful applications
- 18,279
Basis of Allocation
Success Rate Trend
Each line runs from the lowest application tier to the highest tier within its own pool. Hover or tap a point for the exact tier.
Pool APool B
| Pool | Applied shares | Applied lots | Valid applications | Successful applications | Success rate | Allocated shares | Allocated lots | Allotted % |
|---|---|---|---|---|---|---|---|---|
| A | 200 | 1 | 52,066 | 261 | 0.5% | 0-200 | 0-1 | 0.5% |
| A | 400 | 2 | 23,660 | 173 | 0.73% | 0-200 | 0-1 | 0.37% |
| A | 600 | 3 | 10,879 | 100 | 0.92% | 0-200 | 0-1 | 0.31% |
| A | 800 | 4 | 5,944 | 64 | 1.08% | 0-200 | 0-1 | 0.27% |
| A | 1,000 | 5 | 11,577 | 140 | 1.21% | 0-200 | 0-1 | 0.24% |
| A | 1,200 | 6 | 4,802 | 64 | 1.33% | 0-200 | 0-1 | 0.22% |
| A | 1,400 | 7 | 2,997 | 44 | 1.47% | 0-200 | 0-1 | 0.21% |
| A | 1,600 | 8 | 3,065 | 48 | 1.57% | 0-200 | 0-1 | 0.2% |
| A | 1,800 | 9 | 2,092 | 35 | 1.67% | 0-200 | 0-1 | 0.19% |
| A | 2,000 | 10 | 17,326 | 304 | 1.75% | 0-200 | 0-1 | 0.18% |
| A | 3,000 | 15 | 5,970 | 131 | 2.19% | 0-200 | 0-1 | 0.15% |
| A | 4,000 | 20 | 5,261 | 135 | 2.57% | 0-200 | 0-1 | 0.13% |
| A | 5,000 | 25 | 7,580 | 220 | 2.9% | 0-200 | 0-1 | 0.12% |
| A | 6,000 | 30 | 4,023 | 129 | 3.21% | 0-200 | 0-1 | 0.11% |
| A | 7,000 | 35 | 2,518 | 88 | 3.49% | 0-200 | 0-1 | 0.1% |
| A | 8,000 | 40 | 2,521 | 95 | 3.77% | 0-200 | 0-1 | 0.09% |
| A | 9,000 | 45 | 1,982 | 79 | 3.99% | 0-200 | 0-1 | 0.09% |
| A | 10,000 | 50 | 15,265 | 645 | 4.23% | 0-200 | 0-1 | 0.08% |
| A | 20,000 | 100 | 10,495 | 647 | 6.16% | 0-200 | 0-1 | 0.06% |
| A | 30,000 | 150 | 6,579 | 506 | 7.69% | 0-200 | 0-1 | 0.05% |
| A | 40,000 | 200 | 5,398 | 485 | 8.98% | 0-200 | 0-1 | 0.04% |
| A | 50,000 | 250 | 4,169 | 424 | 10.17% | 0-200 | 0-1 | 0.04% |
| A | 60,000 | 300 | 3,349 | 376 | 11.23% | 0-200 | 0-1 | 0.04% |
| A | 70,000 | 350 | 2,139 | 261 | 12.2% | 0-200 | 0-1 | 0.03% |
| A | 80,000 | 400 | 2,198 | 289 | 13.15% | 0-200 | 0-1 | 0.03% |
| A | 90,000 | 450 | 1,594 | 223 | 13.99% | 0-200 | 0-1 | 0.03% |
| A | 100,000 | 500 | 10,413 | 1,542 | 14.81% | 0-200 | 0-1 | 0.03% |
| A | 200,000 | 1,000 | 7,550 | 1,632 | 21.62% | 0-200 | 0-1 | 0.02% |
| B | 300,000 | 1,500 | 7,447 | 2,235 | 30.01% | 0-200 | 0-1 | 0.02% |
| B | 400,000 | 2,000 | 3,755 | 1,278 | 34.03% | 0-200 | 0-1 | 0.02% |
| B | 500,000 | 2,500 | 2,419 | 907 | 37.49% | 0-200 | 0-1 | 0.01% |
| B | 600,000 | 3,000 | 1,770 | 719 | 40.62% | 0-200 | 0-1 | 0.01% |
| B | 700,000 | 3,500 | 1,010 | 439 | 43.47% | 0-200 | 0-1 | 0.01% |
| B | 800,000 | 4,000 | 900 | 415 | 46.11% | 0-200 | 0-1 | 0.01% |
| B | 900,000 | 4,500 | 563 | 273 | 48.49% | 0-200 | 0-1 | 0.01% |
| B | 1,000,000 | 5,000 | 1,116 | 566 | 50.72% | 0-200 | 0-1 | 0.01% |
| B | 1,200,000 | 6,000 | 687 | 378 | 55.02% | 0-200 | 0-1 | 0.01% |
| B | 1,400,000 | 7,000 | 443 | 261 | 58.92% | 0-200 | 0-1 | 0.01% |
| B | 1,600,000 | 8,000 | 408 | 254 | 62.25% | 0-200 | 0-1 | 0.01% |
| B | 1,827,800 | 9,139 | 2,142 | 1,414 | 66.01% | 0-200 | 0-1 | 0.01% |